Answer
Urispas (flavoxate hydrochloride) should not be used during breastfeeding because it is unknown whether flavoxate or its metabolites enter human milk, and a risk to the breastfed child cannot be excluded.
Sources for this answer
- Urispas 200mg Film-coated TabletsRecordati Pharmaceuticals Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked